Dr. Michel Vulfovich, MD

Dr. Vulfovich practices at Memorial Division of Cancer Institute in Hollywood, Florida.

Dr. Vulfovich's NPI, 1619185741, was assigned on May 21, 2007. Dr. Vulfovich graduated from Universidad Anahuac School of Medicine in 2002. Dr. Vulfovich holds Florida license ME100413.

Dr. Vulfovich's primary practice is Memorial Division of Cancer Institute, at 1150 N 35th Ave, Hollywood, FL 33021 in Broward County. The practice phone is (954) 265-4325.

Dr. Vulfovich's primary practice is Memorial Division of Cancer Institute in Hollywood, Florida. Dr. Vulfovich is also affiliated with Memorial Regional Hospital. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Vulfovich to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vulfovich practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vulfovich's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vulfovich is board certified in hematology by the American Board of Internal Medicine. Dr. Vulfovich is licensed in Florida.

Dmand AI lists chronic anemia, chronic embolism thrombosis, colorectal cancer and deep vein thrombosis (DVT) among the conditions Dr. Vulfovich treats.

CMS data shows 349 Medicare services from Dr. Vulfovich across 6 procedure codes in 2024, for 143 Medicare patients. Medicare paid $29,404 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Vulfovich in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vulfovich's median patient age at 59, with 63% women.

In 2024, Dr. Vulfovich wrote 538 Medicare Part D claims for 119 patients. 82% of them were for generic drugs. CMS names the drug for 364 of them, across 12 drugs with 11 or more claims each, at $113,351 in total drug cost. In 2023, CMS named 260 claims across 11 drugs.

Dr. Vulfovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vulfovich as offering telehealth.

Dmand AI links 6 papers to Dr. Vulfovich, published from 2024 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal and Antineoplastic Agents. Dr. Vulfovich has published most often in Int J Mol Sci. Dr. Vulfovich's most frequent co-authors are Nabil F. Saba, MD, Shivani Manoj Dalal, MD and Pablo Ferraro, MD.

Dmand AI links Dr. Vulfovich to 1 clinical trial.

CMS Open Payments shows 15 general payments to Dr. Vulfovich from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 60% of the total. GlaxoSmithKline, LLC. paid the most, $1,088.

Dr. Vulfovich graduated from Universidad Anahuac School of Medicine in 2002.

Dr. Vulfovich is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.